Small-Cap Momentum Watch: Upcoming Catalysts for May 18–22

From operational updates to conference participation, we’ve highlighted the small-cap events that could drive attention this week.

--

Companies Participating in the LD Micro Invitational XVI

The LD Micro Invitational XVI will take place May 17–19, 2026, at the Luxe Sunset Boulevard Hotel in Los Angeles, California. The event brings together investors, analysts, industry professionals, and executives from micro-cap and small-cap companies for presentations, direct engagement, and investor networking.

Participating companies include: ● LFMD • LVO • ELUT • USEG • LINK • LOT ● KAPA • DHX • OBAI • GAME • BESS • NTWK ● GAIA • ROC • EEIQ • MYSE • UPXI • LITB ● AIB • TACT • BRFH • KUST • ZENA

Companies Participating in the H.C. Wainwright 4th Annual BioConnect Investor Conference

The H.C. Wainwright 4th Annual BioConnect Investor Conference will be held on May 19, 2026, in New York, New York. The event connects investors with life sciences companies through company presentations, one-on-one investor meetings, and discussions with H.C. Wainwright investment banking and research teams.

Participating companies include: ● MIST • CRDL • ZNTL • CRBU • BMEA • CNTB ● RANI • VSTM • HURA • CMPX • NBP • LXRX ● RZLT • NUVB • QSI • FATE

Companies Participating in the 2026 RBC Capital Markets Global Healthcare Conference

The 2026 RBC Capital Markets Global Healthcare Conference will be held May 19–20, 2026, in New York, New York. This invitation-only event brings together healthcare industry leaders, innovators, analysts, and investors for networking, strategic discussions, and insights into emerging trends and investment opportunities across the global healthcare sector.

Participating companies include: ● ATYR • CYH • PYXS • IRD ● NMRA • PLRX • NUVB • CATX

Other companies with material events this week:

● MBOT - announced it will host an analysts and investors conference call on Monday, May 18, 2026, at 3:00 p.m. ET to review recent progress of the Full Market Release (FMR) of the LIBERTY® Endovascular Robotic System and address information recently misrepresented in an unaffiliated third-party article.

● BFRI - announced the return of the Hats On Campaign for its second consecutive year. The social media awareness initiative will run May 18–24, 2026, culminating on Global AK Awareness Day, to help raise awareness of actinic keratosis and the importance of sun protection.

● OPEN - announced that CEO Kaz Nejatian will present at the J.P. Morgan 2026 Global Technology, Media and Communications Conference on Monday, May 18, 2026.

● BMR - announced it will demonstrate its ML-safe video data stack for autonomous vehicles at Smart Mobility Summit 2026, taking place May 17–18 in Tel Aviv.

● SKYE - announced that the CBeyond™ Expansion Study (Part C) Cohort Review Committee meeting is scheduled for May 18, 2026, to evaluate available safety data and potential progression to Cohort 2.

● ATHE - will present data from its Multiple System Atrophy (MSA) program at multiple May conferences. Daniel Claassen, M.D., M.S., will present ATH434 Phase 2 data at the MDSANZ Scientific Meeting in Sydney, Australia, taking place May 15–17, 2026. CEO David Stamler, M.D., will deliver an oral presentation titled “ATH434 Clinical Update and Phase 3 Planning” at MSA Symposium 2026 in London on May 18, 2026, from 16:15–17:00 local time.

● PRZO - will participate in SOF Week 2026, taking place May 18–21 in Tampa, Florida, one of the premier global events for Special Operations Forces and USSOCOM.

● IQST - announced that IQSTEL and its digital health partner plan to officially introduce their joint digital health solutions during International Telecoms Week (ITW) 2026 in Washington, D.C., taking place May 18–21, 2026.

● BJDX - announced that an abstract related to its Symphony™ IL-6 Test has been accepted for presentation at the 2026 Society of Academic Emergency Medicine Annual Meeting in Atlanta, Georgia, taking place May 18–21, 2026. The presentation will highlight findings from the SYMON-I multicenter pilot sepsis study evaluating IL-6 levels and organ dysfunction.

● LASE - announced it has been selected to participate in Accelerator Alley at SOF Week 2026, taking place May 18–21, 2026, in Tampa, Florida, where the Company will showcase laser technologies for defense and special operations applications.

● SCNI - announced that members of its leadership team will lead a strategic roundtable discussion at the 7th Dermatology Drug Development Summit Europe, taking place May 19–21, 2026, in Amsterdam, Netherlands.

● CCC - announced that management will present at the J.P. Morgan 2026 Global Technology, Media and Communications Conference in Boston on Tuesday, May 19, 2026, at 4:15 p.m. ET.

● ATOS - announced it will host a virtual key opinion leader event focused on clinical and translational data supporting development of (Z)-endoxifen as a next-generation endocrine therapy for ER-positive breast cancer on Tuesday, May 19, 2026, from 1:00–2:00 p.m. PT.

● LFCR - announced participation at CDMO Live Europe, taking place May 19–21, 2026, in Rotterdam, Netherlands.

● ADAG - announced that senior management will participate in one-on-one investor meetings and a fireside chat at the Stifel Annual Virtual Oncology Event on May 19–20, 2026.

● PHIO - announced that CEO Robert Bitterman will participate in a fireside chat hosted by Force Family Office on Tuesday, May 19, 2026, discussing INTASYL® siRNA technology and future approaches in dermatologic oncology alongside dermatologist Dr. Mary Spellman.

● EVGN - announced participation in the 24th Schrödinger European User Group Meeting in Munich, Germany, taking place May 19–21, 2026.

● CGEN - announced that management will present at the 2026 Stifel Virtual Targeted Oncology Forum on Tuesday, May 19, 2026, from 10:00–10:25 a.m. ET.

● CCLD - announced it will host its 2026 Analyst Day at the Nasdaq MarketSite in New York City on Tuesday, May 19, 2026, highlighting strategic direction, innovation, and financial performance.

● NAGE - announced participation in the 4th Annual Benchmark Consumer One-On-One Conference on May 19, 2026, at the New York Athletic Club, with CEO Rob Fried and CFO Ozan Pamir conducting investor meetings.

● ANTX - announced that CEO Eric Easom will participate in a fireside chat at the 2026 Stifel Virtual Targeted Oncology Forum on May 19, 2026, at 4:00 p.m. ET, with management also available for one-on-one meetings.

● DEFT - announced a partnership with OMFIF’s Digital Monetary Institute and confirmed participation at the OMFIF Digital Money Summit 2026 in London on May 19–20, 2026.

● OKUR - will participate as an exhibitor and sponsor at the ISSVA World Congress 2026 in Philadelphia, taking place May 19–22, 2026.

● SCWO - announced participation at the Federation of New York Solid Waste Association Annual Conference from May 17–20 and JETC 2026 from May 19–21 in Portland, Oregon, where the Company will discuss SCWO applications for PFAS destruction and waste management.

● CBAT - announced it will present at the Sidoti Micro-Cap Virtual Conference taking place May 20–21, 2026.

● BCDA - announced that primary results from the CardiAMP autologous cell therapy refractory angina cohort have been accepted for oral presentation at EuroPCR on May 20, 2026.

● INTZ - announced that CEO Tony Scott will present and host one-on-one meetings with investors at the Sidoti Micro Cap Conference on May 20, 2026.

● MYO - announced participation in two investor conferences, including the Alliance Global Partners Annual Healthcare Company Showcase on May 20, 2026, and Sidoti’s Virtual Micro Cap Conference on May 20–21, 2026.

● MGNX - announced that CEO Eric Risser will participate in a fireside chat at the Stifel 2026 Virtual Targeted Oncology Forum on Wednesday, May 20, 2026, at 10:30 a.m. ET.

● GWH - announced participation in the Sidoti Micro-Cap Virtual Conference on May 20, 2026, where CEO Drew Buckley will host a presentation and investor meetings discussing quarterly results, technology validation, and commercial opportunities.

● VIVO - announced that CIO Alex Cuppage will present at KBRA’s European Data Centers Event on May 20, 2026, discussing VivoPower’s AI infrastructure and powered land strategy.

● IKT - announced that IKT-001 preclinical and Phase 1 data will be presented at the ATS International Conference in Orlando, Florida, on May 17 and May 20, 2026.

● RPAY - announced participation at the Truist Securities 27th Annual Financial Services Conference in New York on Wednesday, May 20, 2026.

● ANGX - announced participation in the B. Riley Securities 26th Annual Investor Conference taking place May 20–21, 2026, in Marina del Rey, California.

● CGTX - announced it received an FDA meeting invitation for May 20, 2026, to discuss plans for a registrational study of zervimesine in dementia with Lewy body psychosis.

● GERN - announced participation in the 2026 Stifel Virtual Targeted Oncology Forum with a virtual presentation scheduled for Wednesday, May 20, 2026, at 12:00 p.m. ET.

● HOVR - announced participation in the Sidoti Micro Cap Conference taking place virtually May 20–21, 2026, including a company presentation and investor meetings.

● TTGT - announced that CEO Gary Nugent will present at the J.P. Morgan Global Technology, Media and Communications Conference in Boston on May 20, 2026, at 12:00 p.m. ET.

● MLCI - announced participation in the B. Riley Securities 2026 Annual Investor Conference taking place May 20–21, 2026, in Marina del Rey, California.

● PSTV - announced presentation of new CNSide® health economics data at the ISPOR 2026 Annual Meeting in Philadelphia, Pennsylvania, taking place May 17–20, 2026, highlighting potential reductions in leptomeningeal metastases healthcare costs through earlier diagnosis and treatment management.

● BRLT - announced participation in the B. Riley Securities Annual Investor Conference in Marina del Rey, California, on May 21, 2026, with investor meetings scheduled throughout the day.

● TOI - announced that CEO Dr. Daniel Virnich and CFO Rob Carter will participate in the B. Riley Securities Institutional Investor Conference on May 21, 2026, including a fireside chat from 9:00–9:40 a.m. PT.

● CRIS - announced that an abstract covering a Phase I trial of emavusertib in combination with gemcitabine and nab-paclitaxel in pancreatic cancer will be available online at ASCO on May 21, 2026, at 5:00 p.m. EDT.

● TBLA - announced participation in the B. Riley Investor Conference on Thursday, May 21, 2026.

● INAB - announced multiple scientific presentations in May and June 2026 and will host an R&D Day on May 21, 2026, highlighting advances across its gamma-delta T cell therapy pipeline.

● RBBN - announced participation in the B. Riley Securities 26th Annual Investor Conference on May 21, 2026.

● RGP - announced that its board approved a quarterly cash dividend of $0.07 per share payable June 19, 2026, to shareholders of record on May 21, 2026.

● DVLT - announced that CEO Nathaniel T. Bradley will deliver keynote presentations at AssetRush × Zurich 2026 on May 21, 2026, discussing the future of tokenized assets as Main Strategic Partner of the event.

● GANX - announced an oral presentation at the 3rd International GBA1 Meeting 2026 taking place May 22–23, 2026, in Phoenix, Arizona.

● ACCO - announced that its board declared a quarterly cash dividend of $0.075 per share payable June 17, 2026, to shareholders of record on May 22, 2026.

● IRWD - announced that the FDA accepted and granted priority review for the sNDA for LINZESS in functional constipation patients ages 2–5 years, with a PDUFA target date of May 24, 2026.

--

Disclaimer: All content provided by BigTimePennys Report is for informational purposes only. The information provided should not be considered as a substitute for professional advice, analysis, or guidance. Any investment decisions made based on the information provided are solely at the user's own risk. BigTimePennys Report are not liable for any losses or damages incurred as a result of using this information. BigTimePenny is not operated by a licensed broker, a dealer, or a registered investment adviser. The Securities Litigation Reform Act of 1995 provides safe harbor protection for forward-looking statements made by companies or individuals. It should be noted that any forward-looking statements made by BigTimePennys Report, its authors, are not guarantees of future performance or results. These statements are subject to risks, uncertainties, and assumptions that may cause actual results to differ materially from those expressed or implied in the forward-looking statements. The content provided by BigTimePennys Report does not constitute an endorsement, recommendation, or solicitation to buy, sell, or hold any securities or investment products. BigTimePennys Report, its authors, do not endorse or recommend any specific investment strategies, securities, or companies. It is crucial to conduct thorough research and seek advice from a qualified professional before making any investment decisions. Nothing in this article constitutes professional and/or financial advice, nor does any information in the article constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. The user assumes full responsibility for the use of the information provided by BigTimePennys Report. BigTimePennys Report, its authors, disclaim any liability for any direct, indirect, or consequential damages arising from the use or reliance on the information provided. Users should exercise their own judgment and discretion when interpreting and utilizing the information provided. Please note that the content provided by BigTimePennys Report is based on available information and sources believed to be reliable. However, market conditions and regulations may change over time, and there may be inaccuracies or errors in the information provided. It is recommended to verify the information with current and reliable sources before making any investment decisions. Investing in micro-cap companies is highly speculative and carries an extremely high degree of risk. BigTimePenny is not a fiduciary by virtue of any person's use of or access to this content. We were NOT compensated for this article.